Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Enzyme Structure and Function, and Ocular Oncology and Treatments.
Cellular senescence in precancer lesions and early-stage cancers
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial
Polyploid cancer cells reveal signatures of chemotherapy resistance
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial
Early detection of cancer
Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases
Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium
Vasculogenic mimicry in small cell lung cancer
A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma
A physical sciences network characterization of non-tumorigenic and metastatic cells
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates
The GPCR Network: a large-scale collaboration to determine human GPCR structure and function
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors
Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology
High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis